Alessia Privitera obtained her Bachelor’s degree in Biological Sciences and her Master’s degree in Molecular Biology and Genetics from the University of Pavia, Italy. During her master’s, she focused on conjugating gold nanoparticles with trastuzumab for photothermal therapy against HER2+ breast cancer, conducting part of this project at Nova Medical School in Lisbon, Portugal.

Currently, she is doing her PhD research thesis at Humanitas University, specifically in the Circadian Metabolism Lab, under the supervision of Professor Carolina Greco. Her doctoral research delves into the molecular mechanisms underlying circadian disruption in heart failure, with a particular focus on how disruptions in circadian rhythms impact the inflammatory processes underlying heart failure pathogenesis.